Farshad Rashidian, DO
Interventional Pain Medicine · West Chester, PANPI 1639582067
Payments from drug & device makers
Across 406 payments — averaging $47.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$14K
- Nevro Corp.$853
- Medtronic$729
- Vertiflex, Inc.$642
- Boston Scientific$571
- Vertos Medical, Inc.$492
- plus $2K from 28 others
What the payments were for
- Travel & lodging$8,59145%
- Food & beverage$10,49655%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 247 | $13,760 |
| Nevro Corp. | 34 | $853 |
| Medtronic(2 entities) | 18 | $729 |
| Vertiflex, Inc. | 6 | $642 |
| Boston Scientific | 15 | $571 |
| Vertos Medical, Inc. | 8 | $492 |
| AbbVie | 10 | $208 |
| Foundation Fusion Solutions, LLC | 7 | $176 |
| Relievant Medsystems, Inc. | 2 | $159 |
| Azurity Pharmaceuticals, Inc. | 7 | $153 |
| Ossur Americas, Inc. | 3 | $143 |
| Globus Medical | 4 | $120 |
| Vertex | 5 | $109 |
| Si-bone, Inc. | 2 | $99 |
| Flowonix Medical Incorporated | 1 | $90 |
| Averitas Pharma Inc. | 4 | $88 |
| Pfizer | 4 | $81 |
| Saluda Medical Americas, Inc. | 4 | $79 |
| Nalu Medical, Inc. | 3 | $59 |
| Stryker | 1 | $45 |
| Zimmer Biomet | 1 | $44 |
| Painteq LLC | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Appliedvr Inc | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| SPR Therapeutics, Inc | 2 | $34 |
| Trice Medical, Inc. | 1 | $31 |
| Fidia Pharma USA Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $27 |
| Evoke Pharma, Inc. | 1 | $25 |
| Spinal Simplicity, LLC | 1 | $25 |
| GRT US Holding, Inc. | 2 | $24 |
| DJO, LLC | 1 | $19 |
| Olympus America Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$6,929
- Proclaim Family of SCS IPGs$1,494
- Superion ISS$393
- mild Device Kit$324
- Intracept$285
- OCTRODE$248
- SYNCHROMEDII$234
- WAVEWRITER ALPHA$212
- INTELLIS ADAPTIVESTIM$156
- Senza Spinal Cord Stimulation System$125
- S-Series SCS Leads$117
- GENERAL PAIN MANAGEMENT$107
How this compares
$19,087 in reported general payments places this provider in the 85th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 337 | $6,311 |
| LyricaPregabalin | 11 | $5,290 |
| MovantikNaloxegol Oxalate | 11 | $4,495 |
| Gabapentin | 333 | $4,170 |
| Oxycodone Hcl | 218 | $3,329 |
| Tizanidine Hcl | 281 | $2,843 |
| Pregabalin | 196 | $2,659 |
| Duloxetine Hcl | 105 | $1,946 |
| Cyclobenzaprine Hcl | 133 | $1,587 |
| Diclofenac Sodium | 17 | $1,268 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,213 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $693 |
| Meloxicam | 127 | $633 |
| Morphine Sulfate | 17 | $555 |
| Tramadol Hcl | 57 | $394 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerLyrica | $81 | $5,29011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 59 interventional pain medicine providers in Pennsylvania.
Other interventional pain medicine in West Chester
- Nathan MaltezosWest Chester$10K
- Pankaj GargWest Chester$4K
- Michael FishmanLebanon$1.5M
- David ProvenzanoSewickley$1.2M
- Fred KhaloufAltoona$490K
- Keith ZoraState College$268K
- Michael FarrellPittsburgh$23K
- Michael FurmanYork$20K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.